RLMD – relmada therapeutics, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

RLMD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/13

06:08 pm

rlmd

Relmada Therapeutics (RLMD) was given a new $10.00 price target by Mizuho.

Low Report

Relmada Therapeutics (RLMD) was given a new $10.00 price target by Mizuho.

Report

3/12

10:33 pm

rlmd

Why Relmada Therapeutics (RLMD) Is Up 38.8% After $160M Raise And Positive NDV-01 Phase 2 Data [Yahoo! Finance]

Medium Report

Why Relmada Therapeutics (RLMD) Is Up 38.8% After $160M Raise And Positive NDV-01 Phase 2 Data [Yahoo! Finance]

Report

3/12

07:00 am

rlmd

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

Low Report

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

Report

3/10

11:41 am

rlmd

A Look At Relmada Therapeutics (RLMD) Valuation After NDV-01 Phase 2 Update And US$160 Million Private Placement [Yahoo! Finance]

Medium Report

A Look At Relmada Therapeutics (RLMD) Valuation After NDV-01 Phase 2 Update And US$160 Million Private Placement [Yahoo! Finance]

Report

3/9

07:17 pm

rlmd

50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today [Yahoo! Finance]

Medium Report

50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today [Yahoo! Finance]

Report

3/9

04:42 pm

rlmd

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]

Medium Report

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]

Report

3/9

04:30 pm

rlmd

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Medium Report

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Report

3/9

07:32 am

rlmd

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer [Yahoo! Finance]

High Report

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/13/2025

04:01 pm

rlmd

relmada therapeutics, inc.

MISS Report

-0.5%

relmada therapeutics, inc.

Report

8/7/2025

04:05 pm

rlmd

relmada therapeutics, inc.

MISS Report

-2.4%

relmada therapeutics, inc.

Report

5/12/2025

04:01 pm

rlmd

relmada therapeutics, inc.

MISS Report

-2.1%

relmada therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

1/23

08:04 am

Upgrades

Market Perform

Outperform

Leerink Partners

Medium

Report

-9.1%

Report

1/23

07:04 am

Upgrades

Market Perform

Outperform

Leerink Partners

Medium

Report

-5.8%

Report

12/22

07:18 am

Initiates

Buy

Jefferies

Low

Report

0.9%

Report

12/22

07:18 am

Initiates

Buy

Jefferies

Low

Report

0.9%

Report

12/21

07:08 pm

Initiates

BUY

JEFFERIES

Medium

Report

3.9%

Report

12/21

07:08 pm

Initiates

BUY

JEFFERIES

Medium

Report

3.9%

Report

Date

Time

Symbol

Headline

Impact

3/9

07:11 am

rlmd

Form 8-K RELMADA THERAPEUTICS, For: Mar 09

High Report

Form 8-K RELMADA THERAPEUTICS, For: Mar 09

Report

2/17

12:19 pm

rlmd

Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Squadron Capital Management LLC

Medium Report

Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Squadron Capital Management LLC

Report

2/17

09:15 am

rlmd

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Spruce Street Capital LP

Medium Report

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Spruce Street Capital LP

Report

2/12

09:13 am

rlmd

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.

Low Report

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.

Report

2/6

04:32 pm

rlmd

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: JANUS HENDERSON GROUP PLC

Medium Report

Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: JANUS HENDERSON GROUP PLC

Report

1/30

05:14 pm

rlmd

Form 424B5 RELMADA THERAPEUTICS,

Medium Report

Form 424B5 RELMADA THERAPEUTICS,

Report

12/16

09:31 am

rlmd

Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: TRAVERSA SERGIO

Low Report

Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: TRAVERSA SERGIO

Report

12/16

09:30 am

rlmd

Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: Ence Chuck

Medium Report

Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: Ence Chuck

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.